258 related articles for article (PubMed ID: 32929275)
21. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
[TBL] [Abstract][Full Text] [Related]
22. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
23. A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse.
Singleton K; Parvaze N; Dama KR; Chen KS; Jennings P; Purtic B; Sjaastad MD; Gilpin C; Davis MM; Wülfing C
J Immunol; 2006 Oct; 177(7):4402-13. PubMed ID: 16982875
[TBL] [Abstract][Full Text] [Related]
24. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.
Crawford K; Stark A; Kitchens B; Sternheim K; Pantazopoulos V; Triantafellow E; Wang Z; Vasir B; Larsen CE; Gabuzda D; Reinherz E; Alper CA
Blood; 2003 Sep; 102(5):1745-52. PubMed ID: 12714509
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
[TBL] [Abstract][Full Text] [Related]
26. Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site.
Zaru R; Cameron TO; Stern LJ; Müller S; Valitutti S
J Immunol; 2002 May; 168(9):4287-91. PubMed ID: 11970969
[TBL] [Abstract][Full Text] [Related]
27. Antigen-independent maturation of CD2, CD11a/CD18, CD44, and CD58 expression on thymic emigrants in fetal and postnatal sheep.
Witherden DA; Abernethy NJ; Kimpton WG; Cahill RN
Dev Immunol; 1995; 4(3):199-209. PubMed ID: 8770559
[TBL] [Abstract][Full Text] [Related]
28. T cell regulation of p62(dok) (Dok1) association with Crk-L.
Martelli MP; Boomer J; Bu M; Bierer BE
J Biol Chem; 2001 Dec; 276(49):45654-61. PubMed ID: 11553620
[TBL] [Abstract][Full Text] [Related]
29. Human Oral Epithelial Cells Suppress T Cell Function
Sanchez-Trincado JL; Pelaez-Prestel HF; Lafuente EM; Reche PA
Front Immunol; 2021; 12():740613. PubMed ID: 35126344
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
[TBL] [Abstract][Full Text] [Related]
31. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
[TBL] [Abstract][Full Text] [Related]
32. Structural biology of the cell adhesion protein CD2: from molecular recognition to protein folding and design.
Wilkins AL; Yang W; Yang JJ
Curr Protein Pept Sci; 2003 Oct; 4(5):367-73. PubMed ID: 14529530
[TBL] [Abstract][Full Text] [Related]
33. CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity.
Gollob JA; Ritz J
Ann N Y Acad Sci; 1996 Oct; 795():71-81. PubMed ID: 8958918
[TBL] [Abstract][Full Text] [Related]
34. The expression of CD2 in chronic HBV infection.
Li J; Qi B; Chen P; He L; Wang P; Ji Y; Xie M
Cell Mol Immunol; 2008 Feb; 5(1):69-73. PubMed ID: 18318997
[TBL] [Abstract][Full Text] [Related]
35. Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+ T cells is independent of cell activation.
Majeau GR; Whitty A; Yim K; Meier W; Hochman PS
Cell Adhes Commun; 1999; 7(3):267-79. PubMed ID: 10626910
[TBL] [Abstract][Full Text] [Related]
36. The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction.
Kearney A; Avramovic A; Castro MA; Carmo AM; Davis SJ; van der Merwe PA
J Biol Chem; 2007 May; 282(18):13160-6. PubMed ID: 17344209
[TBL] [Abstract][Full Text] [Related]
37. Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.
Parajuli P; Sable R; Shrestha L; Dahal A; Gauthier T; Taneja V; Jois S
Chem Biol Drug Des; 2021 Mar; 97(3):607-627. PubMed ID: 32946175
[TBL] [Abstract][Full Text] [Related]
38. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
[TBL] [Abstract][Full Text] [Related]
39. Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds.
Fonseca AM; Pereira CF; Porto G; Arosa FA
Cell Immunol; 2003 Jul; 224(1):17-28. PubMed ID: 14572797
[TBL] [Abstract][Full Text] [Related]
40. Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin.
Orlik C; Deibel D; Küblbeck J; Balta E; Ganskih S; Habicht J; Niesler B; Schröder-Braunstein J; Schäkel K; Wabnitz G; Samstag Y
Cell Mol Immunol; 2020 Apr; 17(4):380-394. PubMed ID: 31324882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
